Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


MiR-206 Attenuates Denervation-Induced Skeletal Muscle Atrophy in Rats Through Regulation of Satellite Cell Differentiation via TGF-β1, Smad3, and HDAC4 Signaling

Qiang Kai Huang, Hu-Yuan Qiao, Ming-Huan Fu, Gang Li, Wen-Bin Li, Zhi Chen, Jian Wei, Bing-Sheng Liang

China (mainland) Department of Orthopedics, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, China (mainland)

Med Sci Monit 2016; 22:1161-1170

DOI: 10.12659/MSM.897909

Available online:

Published: 2016-04-07

BACKGROUND: Denervation-induced skeletal muscle atrophy results in significant biochemical and physiological changes potentially leading to devastating outcomes including increased mortality. Effective treatments for skeletal muscle diseases are currently not available. Muscle-specific miRNAs, such as miR-206, play an important role in the regulation of muscle regeneration.
The aim of the present study was to examine the beneficial effects of miR-206 treatment during the early changes in skeletal muscle atrophy, and to study the underlying signaling pathways in a rat skeletal muscle atrophy model.
MATERIAL AND METHODS: The rat denervation-induced skeletal muscle atrophy model was established. miRNA-206 was overexpressed with or without TGF-β1 inhibitor in the rats. The mRNA and protein expression of HDAC4, TGF-β1, and Smad3 was determined by real-time PCR and western blot. The gastrocnemius muscle cross-sectional area and relative muscle mass were measured. MyoD1, TGF-β1, and Pax7 were determined by immunohistochemical staining.
RESULTS: After sciatic nerve surgical transection, basic muscle characteristics, such as relative muscle weight, deteriorated continuously during a 2-week period. Injection of miR-206 (30 μg/rat) attenuated morphological and physiological deterioration of muscle characteristics, prevented fibrosis effectively, and inhibited the expression of TGF-β1 and HDAC4 as assessed 2 weeks after denervation. Moreover, miR-206 treatment increased the number of differentiating (MyoD1+/Pax7+) satellite cells, thereby protecting denervated muscles from atrophy. Interestingly, the ability of miR-206 to govern HDAC4 expression and to attenuate muscle atrophy was weakened after pharmacological blockage of the TGF-b1/Smad3 axis.
CONCLUSIONS: TGF-β1/Smad3 signaling pathway is one of the crucial signaling pathways by which miR-206 counteracts skeletal muscle atrophy by affecting proliferation and differentiation of satellite cells. miR-206 may be a potential target for development of a new strategy for treatment of patients with early denervation-induced skeletal muscle atrophy.

Keywords: Denervation, Cell Differentiation - genetics, Animals, Histone Deacetylases - metabolism, MicroRNAs - metabolism, Muscle, Skeletal - pathology, Muscular Atrophy - therapy, Myoblasts - metabolism, RNA, Messenger - metabolism, Random Allocation, Rats, Rats, Sprague-Dawley, Real-Time Polymerase Chain Reaction, Satellite Cells, Skeletal Muscle - metabolism, Sciatic Nerve - surgery, Signal Transduction, Smad3 Protein - metabolism, Transforming Growth Factor beta1 - metabolism